Pharsight

Magnesium Hydroxide And Omeprazole And Sodium Bicarbonate patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6489346 SANTARUS Substituted benzimidazole dosage forms and method of using same
Jul, 2016

(7 years ago)

US7399772 SANTARUS Substituted benzimidazole dosage forms and method of using same
Jul, 2016

(7 years ago)

US6645988 SANTARUS Substituted benzimidazole dosage forms and method of using same
Jul, 2016

(7 years ago)

US6699885 SANTARUS Substituted benzimidazole dosage forms and methods of using same
Jul, 2016

(7 years ago)

Magnesium Hydroxide And Omeprazole And Sodium Bicarbonate is owned by Santarus.

Magnesium Hydroxide And Omeprazole And Sodium Bicarbonate contains Magnesium Hydroxide; Omeprazole; Sodium Bicarbonate.

Magnesium Hydroxide And Omeprazole And Sodium Bicarbonate has a total of 4 drug patents out of which 4 drug patents have expired.

Expired drug patents of Magnesium Hydroxide And Omeprazole And Sodium Bicarbonate are:

  • US6489346
  • US7399772
  • US6645988
  • US6699885

Magnesium Hydroxide And Omeprazole And Sodium Bicarbonate was authorised for market use on 04 December, 2009.

Magnesium Hydroxide And Omeprazole And Sodium Bicarbonate is available in tablet;oral dosage forms.

Magnesium Hydroxide And Omeprazole And Sodium Bicarbonate can be used as short-term treatment (4-8 weeks) of active benign gastric ulcer, short-term treatment of active duodenal ulcer; treatment of heartburn and other symptoms associated with gerd; short-term treatment of erosive esophagitis; maintenance of healing of erosive esophagitis.

The generics of Magnesium Hydroxide And Omeprazole And Sodium Bicarbonate are possible to be released after 16 July, 2016.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE ingredient

Market Authorisation Date: 04 December, 2009

Treatment: Short-term treatment of active duodenal ulcer; Treatment of heartburn and other symptoms associated with gerd; Short-term treatment of erosive esophagitis; Maintenance of healing of erosive esophagiti...

Dosage: TABLET;ORAL

More Information on Dosage

MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM BICARBONATE family patents

Family Patents